We welcome you to GTCbio’s 14th Stem Cell Research & Regenerative Medicine Conference. This conference presents information regarding cutting-edge developments in all areas of stem cell research, including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine, stem cell reprogramming, immunotherapy, cell therapy in diabetes, and regulatory policies regarding stem cell research.
- Advances in Adult & Pluripotent Stem Cell Research
- Revolution in Immunotherapy
- What’s in the Pipeline: Pre-clinical & Clinical Strategies
- Joint Plenary Session: Where do We Stand with Cell Therapy in Diabetes?
This conference is part of the Stem Cell Summit taking place April 5-7, 2017 in Boston, MA which includes two back-to-back conferences:
April 5-6, 2017: 14th Stem Cell Research & Regenerative Medicine Conference
April 6-7, 2017: 6th Stem Cell Product Development & Commercialization Conference
We look forward to seeing you at the conference!
The 2017 Advisory Committee
|2017 Advisory Board Members|
|Stephen Chang, The New York Stem Cell Foundation|
|Douglas Losordo, Caladrius Biosciences|
|Robert Deans, BlueRock Therapeutics|
|Alain Vertes, GmbH|
|Daniel Anderson, Massachusetts Institute of Technology|
|Edward Lanphier, Sangamo Biosciences|
|Khalid Shah, Harvard Medical School; Massachusetts General Hospital|
|Yang (Ted) Teng, Harvard University and Spaulding Rehabilitation Hospital|
|Anthony Ting, Athersys|
|James Ankrum, University of Iowa|
|Hardy T S Kagimoto, Healios K.K (RIKEN Venture)|
|Robert Halliwell, University of the Pacific|
|Devyn Smith, Pfizer|
|Jiwen Zhang, GE Healthcare|
|Julie G. Allickson, Wake Forest Institute for Regenerative Medicine|
|Tiina Palomaki, Finnish Medicines Agency|
|Satish Medicetty , GTCbio|
Amber Kempf at 626-256-6405 or amber.kempf [at] gtcbio.com
Viracor Eurofins provides clinical trial biomarker testing services with expertise in custom assay transfer, design and validation for phase I-IV trials. Our CAP/CLIA and NY state accredited laboratory has over 30 years of experience in molecular testing, immune response monitoring, vaccine safety/efficacy assessment, allergy and hypersensitivity testing.
Cancer Genetics Inc. (CGI; Nasdaq: CGIX) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State. CGI has established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.
BioSpherix will be exhibiting the Xvivo System, world’s first and only cytocentric barrier isolator optimized for cells. Economical and practical alternative to cleanrooms for cGMP compliant production of cells for clinical use. Get better contamination, process and quality control. Stop by the BioSpherix booth to learn more about the only total quality platform for cells!
Diagenode, the leading provider of complete solutions for epigenetics research, offers innovative shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. Our latest innovations include a full automation system, ChIP-seq kits for only 10,000 cells, and the industry’s most validated antibodies.
Absorption Systems assists pharmaceutical and medical device companies in identifying and overcoming ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) barriers in the development of drugs and medical devices. The company's mission is to continually develop innovative research tools that can be used to accurately predict human outcomes or to explain unanticipated human outcomes whey they occur.
Biological Industries USA (BI-USA) offers a comprehensive portfolio of optimized, innovative solutions for general cell culture, stem cell research, and cell therapy applications. With our state-of-the-art serum-free, xeno-free stem cell media produced under cGMP and ISO-certified regulations, we strive to offer an unmatched commitment to quality, defining BI-USA’s culture of excellence.
CBSET is a nonprofit biomedical research institute with a mission is to advance therapeutics development through high-quality services. We collaborate with med tech and pharmaceutical sponsors with a GLP-compliant, AAALAC-accredited facility including vivaria, catheterization / imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.